New Data from IMAgINE 1 Trial Provide Insights on Biologic Use in Pediatric Crohn’s Disease

Interferon-Free Therapies Head for Approval in Hepatitis C on the Basis of Phase 3 Data

Bile Acid Malabsorption Proves to Be Surprisingly Frequent Source of Readily Reversible Chronic Diarrhea

Optimization of PPI Therapy in GERD: Need for Acid Control Over Each 24-hour Period

Adhesion Factor Inhibitors Fundamentally Shift Risk-Benefit of Biologics in IBD

National Survey Reveals Majority of PPI Users Achieve Inadequate Relief

Raising the Rate of Successful GERD Control: Focus on Improved Pharmacokinetics of Acid Suppressant Therapy